Newsletter | September 28, 2024

09.28.24 -- Simplifying The Path To Market For AAV Gene Therapies

Readers of Life Science Connect communities tell us that our webinars are helpful, informative, and serve as valuable tools for evaluating solutions and suppliers. Below are just a few of the recent Cell & Gene webinars that have taken place in our communities.

Path To IND: AAV Transient Transfection, Producer Cell Line Platforms

Current AAV manufacturing challenges include scalability, complex supply chains, and inconsistent results between batches. Discover a streamlined AAV transient transfection platform that de-risks your path to IND and reduces complexity and timeline for process and analytical development.

AAV Analytics: Key Considerations When Developing A Clinical Program

Inadequate analytical development and process validation pose challenges for advanced therapies. Finding partners with the skills to optimize AAV processes is crucial for minimizing variability and risk. Explore considerations for advancing your AAV gene therapy from concept to commercialization.

Accelerating Rare Disease Treatments From Concept To Cure

Can the expedited approach used for COVID-19 be replicated to develop curative therapies for rare diseases? This webinar investigates the crucial factors for speeding up the development of curative therapies, highlighting the strategic contribution CDMOs can make in this groundbreaking process.